(CCJ) Cameco - Overview
Sector: Energy | Industry: Uranium | Exchange: NYSE (USA) | Market Cap: 45.875m USD | Total Return: 78.8% in 12m
Avg Turnover: 356M
EPS Trend: 78.9%
Qual. Beats: 2
Rev. Trend: 96.3%
Qual. Beats: 0
Warnings
P/E ratio 97.5
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Cameco Corporation (CCJ) is a vertically integrated nuclear fuel provider headquartered in Saskatoon, Canada. The company operates through three primary segments: Uranium, Fuel Services, and Westinghouse, covering the entire nuclear fuel cycle from exploration and mining to reactor maintenance and technology manufacturing. Its global footprint services commercial utilities and government agencies across the Americas, Europe, and Asia.
The uranium sector is characterized by long-term contracting cycles, as nuclear utilities typically secure fuel supplies years in advance to ensure reactor stability. Unlike many commodity producers, Cameco’s acquisition of a majority stake in Westinghouse allows it to capture value from both raw material extraction and high-margin downstream services, such as plant modifications and engineering support. Investors can further evaluate these segment-specific growth drivers on ValueRay.
- Rising global uranium spot prices drive higher margins for long-term supply contracts
- Nuclear energy policy shifts in G7 nations accelerate demand for domestic supply
- Westinghouse segment acquisition diversifies revenue through nuclear reactor maintenance and services
- Operational risks at flagship McArthur River and Cigar Lake mines impact production
- Geopolitical instability in Kazakhstan increases market reliance on Canadian uranium production sources
| Net Income: 650.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.66 > 1.0 |
| NWC/Revenue: 30.71% < 20% (prev 28.73%; Δ 1.98% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.25b > Net Income 650.7m |
| Net Debt (202.1m) to EBITDA (1.10b): 0.18 < 3 |
| Current Ratio: 3.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (435.6m) vs 12m ago 0.03% < -2% |
| Gross Margin: 29.83% > 18% (prev 0.26%; Δ 2.96k% > 0.5%) |
| Asset Turnover: 42.49% > 50% (prev 35.08%; Δ 7.41% > 0%) |
| Interest Coverage Ratio: 10.18 > 6 (EBITDA TTM 1.10b / Interest Expense TTM 77.1m) |
| A: 0.15 (Total Current Assets 1.61b - Total Current Liabilities 522.7m) / Total Assets 7.27b |
| B: 0.37 (Retained Earnings 2.69b / Total Assets 7.27b) |
| C: 0.09 (EBIT TTM 785.3m / Avg Total Assets 8.32b) |
| D: 2.26 (Book Value of Equity 4.94b / Total Liabilities 2.19b) |
| Altman-Z'' = 5.20 = AAA |
| DSRI: 0.70 (Receivables 140.4m/185.4m, Revenue 3.54b/3.29b) |
| GMI: 0.88 (GM 29.83% / 26.31%) |
| AQI: 0.91 (AQ_t 0.45 / AQ_t-1 0.49) |
| SGI: 1.07 (Revenue 3.54b / 3.29b) |
| TATA: -0.08 (NI 650.7m - CFO 1.25b) / TA 7.27b) |
| Beneish M = -3.46 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 105.33 with a total of 2,897,850 shares traded.
Over the past week, the price has changed by -2.57%,
over one month by -15.42%,
over three months by -11.79% and
over the past year by +78.83%.
Cameco has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy CCJ.
- StrongBuy: 10
- Buy: 9
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 132.3 | 25.6% |
P/E Trailing = 97.5278
P/E Forward = 90.9091
P/S = 12.9668
P/B = 8.8112
P/EG = 1.9161
Revenue TTM = 3.54b CAD
EBIT TTM = 785.3m CAD
EBITDA TTM = 1.10b CAD
Long Term Debt = 996.5m CAD (from longTermDebt, last quarter)
Short Term Debt = 3.34m CAD (from shortTermDebt, last fiscal year)
Debt = 999.9m CAD (corrected: LT Debt 996.5m + ST Debt 3.34m)
Net Debt = 202.1m CAD (calculated: Debt 999.9m - CCE 797.8m)
Enterprise Value = 63.3b CAD (63.1b + Debt 999.9m - CCE 797.8m)
Interest Coverage Ratio = 10.18 (Ebit TTM 785.3m / Interest Expense TTM 77.1m)
EV/FCF = 70.32x (Enterprise Value 63.3b / FCF TTM 899.7m)
FCF Yield = 1.42% (FCF TTM 899.7m / Enterprise Value 63.3b)
FCF Margin = 25.44% (FCF TTM 899.7m / Revenue TTM 3.54b)
Net Margin = 18.40% (Net Income TTM 650.7m / Revenue TTM 3.54b)
Gross Margin = 29.83% ((Revenue TTM 3.54b - Cost of Revenue TTM 2.48b) / Revenue TTM)
Gross Margin QoQ = 35.68% (prev 22.24%)
Tobins Q-Ratio = 8.71 (Enterprise Value 63.3b / Total Assets 7.27b)
Interest Expense / Debt = 7.71% (Interest Expense 77.1m / Debt 999.9m)
Taxrate = 19.74% (32.2m / 162.9m)
NOPAT = 630.3m (EBIT 785.3m * (1 - 19.74%))
Current Ratio = 3.08 (Total Current Assets 1.61b / Total Current Liabilities 522.7m)
Debt / Equity = 0.20 (Debt 999.9m / totalStockholderEquity, last quarter 5.08b)
Debt / EBITDA = 0.18 (Net Debt 202.1m / EBITDA 1.10b)
Debt / FCF = 0.22 (Net Debt 202.1m / FCF TTM 899.7m)
Total Stockholder Equity = 6.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 650.7m / Total Assets 7.27b)
RoE = 10.21% (Net Income TTM 650.7m / Total Stockholder Equity 6.37b)
RoCE = 10.65% (EBIT 785.3m / Capital Employed (Equity 6.37b + L.T.Debt 996.5m))
RoIC = 9.65% (NOPAT 630.3m / Invested Capital 6.53b)
WACC = 12.61% (E(63.1b)/V(64.1b) * Re(12.71%) + D(999.9m)/V(64.1b) * Rd(7.71%) * (1-Tc(0.20)))
Discount Rate = 12.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 22.47 | Cagr: 0.15%
[DCF] Terminal Value 65.47% ; FCFF base≈792.4m ; Y1≈908.4m ; Y5≈1.34b
[DCF] Fair Price = 25.79 (EV 11.4b - Net Debt 202.1m = Equity 11.2b / Shares 435.5m; r=12.61% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.88 | EPS CAGR: 42.49% | SUE: 1.22 | # QB: 2
Revenue Correlation: 96.28 | Revenue CAGR: 21.98% | SUE: 0.32 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.35 | Chg30d=-1.65% | Revisions=+0% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.32 | Chg30d=-4.78% | Revisions=+0% | Analysts=8
EPS current Year (2026-12-31): EPS=1.60 | Chg30d=+1.87% | Revisions=+29% | GrowthEPS=+10.8% | GrowthRev=-0.1%
EPS next Year (2027-12-31): EPS=2.65 | Chg30d=+5.14% | Revisions=-25% | GrowthEPS=+66.1% | GrowthRev=+14.4%
[Analyst] Revisions Ratio: +29%